Human Galectin-9 quantitates human Galectin-9 in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human Galectin-9.
Accession number
Lectine liant la bêta-galactoside de 36 kDa ; AA407335 ; AI194909 ; AI265545 ; Ecalectine ; Gal9 ; gal-9 ; galectine 9 ; galectine9 ; galectine-9 ; HOM HD 21 ; HUAT ; lectine soluble liant le galactose 9 (galectine-9) ; lectine, liant le galactose, soluble 5 ; lectine, liant le galactose, soluble 9 ; lectine, liant le galactose, soluble 9 (galectine-9) ; lectine, soluble liant le galactoside 9 ; lectine, liant le galactoside, soluble, 9 ; LGALS35 ; Lgals5 ; LGALS9 ; LGALS9A ; antigène de tumeur HOM-HD-21 ; UAT ; transporteur/canal d’urate ; protéine transporteur/canal d’urate
Dose range
36.86 to 9.000 pg/mL
Sensitivity of the dosage
36 pg/mL
Conjugate
Biotin
Product type
ELISA
Brand
Invitrogen
Human Galectin-9 quantitates human Galectin-9 in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human Galectin-9.
Human Galectin-9 quantitates human Galectin-9 in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human Galectin-9.
Galectins are a family of beta-galactoside binding proteins involved in modulation of cell-cell and cell-matrix interactions. The protein encoded by this gene is a type S lectin. They are overexpressed in the tissue of Hodgkin's disease and can participate in the interaction between H and RS cells with their surrounding cells and can thus play a role in the pathogenesis of this disease and/or its associated immunodeficiency. Several alternative spliced transcription variants have been found for this gene.
Sensitivity
Sensitivity of the dosage: 36 pg/mL.
Measurement range
Dose range: 36.86 to 9.000 pg/mL.
Duration of dosing
Total duration of dosing: 4 h 45 min.
Target
Target: Galectin 9.
Samples
Type of sample: Plasma, Serum, Surnatant (surnatant volume, 50 µl; plasma, 50 µl; serum, 50 µl).